IBRX

IBRX Other Income/Expenses (Net)

-$740.78MTTM · USD

Period ending:

IBRX FY Other Income/Expenses (Net)USD
IBRX FY Other Income/Expenses (Net)2013-12-31: $223.00K2014-12-31: -$609.00K2015-12-31: $1.70M2016-12-31: $3.12M2017-12-31: $2.20M2018-12-31: $1.66M2019-12-31: $1.02M2020-12-31: -$5.15M2021-12-31: -$19.56M2022-12-31: -$65.99M2023-12-31: -$221.64M2024-12-31: -$69.46M2025-12-31: -$95.58M$3.12M-$221.64M
2013-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IBRX other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 13 observations from Dec 31, 2013 to Dec 31, 2025.

Immunitybio Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-95,580,000
-69,463,000
-221,642,000
-65,988,000
-19,559,000
-5,153,000
1,021,000
1,660,000
2,204,000
3,119,000
1,699,000
-609,000
223,000

Compare other income/expenses (net)

All IBRX financial metrics · IBRX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.